XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Public Offerings
A T M Facility
Common Stock
Common Stock
Public Offerings
Common Stock
A T M Facility
Additional Paid-in Capital
Additional Paid-in Capital
Public Offerings
Additional Paid-in Capital
A T M Facility
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 125,957     $ 20     $ 339,218     $ (64) $ (213,217)
Beginning balance, shares at Dec. 31, 2021       20,317,204              
Issuance of common stock upon exercise of stock options 29           29        
Issuance of common stock upon exercise of stock options, shares       12,065              
Issuance of common stock upon vesting of restricted stock units, net, shares       22,115              
Stock-based compensation 2,512           2,512        
Net loss (25,565)                   (25,565)
Other comprehensive income (loss) (192)                 (192)  
Ending balance at Mar. 31, 2022 102,741     $ 20     341,759     (256) (238,782)
Ending balance, shares at Mar. 31, 2022       20,351,384              
Beginning balance at Dec. 31, 2022 151,832     $ 51     467,374     (350) (315,243)
Beginning balance, shares at Dec. 31, 2022       50,560,590              
Issuance of common stock   $ 296,817 $ 13,422   $ 19 $ 1   $ 296,798 $ 13,421    
Issuance of common stock, shares         19,461,538 968,000          
Issuance of common stock upon exercise of warrants 8,960     $ 2     8,958        
Issuance of common stock upon exercise of warrants       1,682,500              
Issuance of common stock upon exercise of stock options 185           185        
Issuance of common stock upon exercise of stock options, shares       61,408              
Issuance of common stock upon vesting of restricted stock units, net of withholding taxes (693)           (693)        
Issuance of common stock upon vesting of restricted stock units, net of withholding taxes, shares       133,669              
Issuance of common stock warrants in connection with term loan 482           482        
Stock-based compensation 3,551           3,551        
Net loss (28,836)                   (28,836)
Other comprehensive income (loss) 110                 110  
Ending balance at Mar. 31, 2023 $ 445,830     $ 73     $ 790,076     $ (240) $ (344,079)
Ending balance, shares at Mar. 31, 2023       72,867,705